drugset / Trial / NCT06988319
Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
Phase 1
Not yet recruiting
15 enrolled
Oregon Health and Science University
Portland Psychotherapy Clinic, Research, and Training Center · collab
NaSingle-groupOpen-labelTreatment
Summary
The primary aim is to determine the feasibility of enrolling and 15 women with chronic pelvic pain (CPP) that have failed one conventional for CPP to obtain preliminary safety data on a single administration of a moderate dose of pharmaceutical grade psilocybin (25 mg) in combination with psychotherapy sessions (two pre-dose preparatory and three post-dose integration sessions).
Timeline
- Start
- 2026-01-01
- Primary completion
- 2026-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Psilocybin | Other / unclassified | 25 mg | — |